These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20889562)

  • 21. Cellular localization of PACAP and its receptors in the ovary of the spotted ray Torpedo marmorata Risso 1880 (Elasmobranchii: Torpediniformes).
    Agnese M; Valiante S; Laforgia V; Andreuccetti P; Prisco M
    J Exp Zool A Ecol Genet Physiol; 2013 Jan; 319(1):1-9. PubMed ID: 23027597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective role of the VIP signaling system.
    Dvoráková MC
    Timely Top Med Cardiovasc Dis; 2005 Oct; 9():E33. PubMed ID: 16341283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis.
    Isobe K; Kaneko M; Kaneko S; Nissato S; Nanmoku T; Takekoshi K; Okuda Y; Kawakami Y
    Regul Pept; 2004 Dec; 123(1-3):29-32. PubMed ID: 15518890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PACAP causes PAC1/VPAC2 receptor mediated hypertension and sympathoexcitation in normal and hypertensive rats.
    Farnham MM; Lung MS; Tallapragada VJ; Pilowsky PM
    Am J Physiol Heart Circ Physiol; 2012 Oct; 303(7):H910-7. PubMed ID: 22886412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors are present and biochemically active in the central nervous system of the pond snail Lymnaea stagnalis.
    Pirger Z; Laszlo Z; Hiripi L; Hernadi L; Toth G; Lubics A; Reglodi D; Kemenes G; Mark L
    J Mol Neurosci; 2010 Nov; 42(3):464-71. PubMed ID: 20396976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatiotemporal Expression Changes of PACAP and Its Receptors in Retinal Ganglion Cells After Optic Nerve Crush.
    Ye D; Yang Y; Lu X; Xu Y; Shi Y; Chen H; Huang J
    J Mol Neurosci; 2019 Jul; 68(3):465-474. PubMed ID: 30415445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.
    Michalski CW; Selvaggi F; Bartel M; Mitkus T; Gorbachevski A; Giese T; Sebastiano PD; Giese NA; Friess H
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G50-7. PubMed ID: 17962362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A subnanomolar concentration of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) pre-synaptically modulates glutamatergic transmission in the rat hippocampus acting through acetylcholine.
    Pecoraro V; Sardone LM; Chisari M; Licata F; Li Volsi G; Perciavalle V; Ciranna L; Costa L
    Neuroscience; 2017 Jan; 340():551-562. PubMed ID: 27816700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of expression and proliferative effect of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors on human astrocytoma cell lines.
    Nakamachi T; Sugiyama K; Watanabe J; Imai N; Kagami N; Hori M; Arata S; Shioda S
    J Mol Neurosci; 2014 Nov; 54(3):388-94. PubMed ID: 25091859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K; Connell TD; Higgins D
    J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.
    Girard BM; Malley SE; Braas KM; May V; Vizzard MA
    J Mol Neurosci; 2010 Nov; 42(3):378-89. PubMed ID: 20449688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PACAP and VIP prevent apoptosis in schwannoma cells.
    Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
    Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
    J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1.
    Njaine B; Martins RA; Santiago MF; Linden R; Silveira MS
    Eur J Neurosci; 2010 Aug; 32(3):311-21. PubMed ID: 20646049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.